Amsurg (AMSG) Tops Q4 EPS by 4c, Offers Guidance

Amsurg (NASDAQ: AMSG) reported Q4 EPS of $0.77, $0.04 better than the analyst estimate of $0.73. Revenue for the quarter came in at $581.8 million versus the consensus estimate of $565.3 million.

Amsurg sees FY2015 EPS of $3.24-$3.32, versus the consensus of $3.27. Amsurg sees FY2015 revenue of $2.44-2.47 billion, versus the consensus of $2.39 billion.

Amsurg sees FY2015 EPS of $0.55-$0.58, versus the consensus of $0.75.

For earnings history and earnings-related data on Amsurg (AMSG) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• ACRES Commercial Realty says labor dispute is hindering hotel sale
• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance